UnityPoint Health - Des Moines

Genitourinary Cancer Research Studies

Renal Cell

S1500: A Randomized, Phase II Efficacy Assessment of Multiple MET Kinase Inhibitors (Cabozantinib, Crizotinib, Savolitinib, and Sunitinib) in Metastatic Papillary Renal Carcinoma (PAPMET)

Prostate

BR001: A Phase I Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple